Caricamento...
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
Anti- tumor Necrosis Factor (anti-TNF) agents are the backbone treatment of moderate to severe cases of inflammatory bowel disease. One of the main drawbacks of these agents is the high cost. The introduction of biosimilar products to anti-TNF agents is expected to lower the cost. Health care provid...
Salvato in:
| Pubblicato in: | Biologics |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966952/ https://ncbi.nlm.nih.gov/pubmed/32021084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S236433 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|